John R. Koenig, Chicago US

John R. Koenig, Chicago, IL US

Patent application number	Description	Published
20080214524	FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR - Compounds of formula (I)	09-04-2008
20080287676	FUSED COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR - The present invention discloses novel compounds of general formula (I)	11-20-2008
20090124666	TRPV1 ANTAGONISTS - Compounds of formula (I)	05-14-2009
20090233953	ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF - The present invention is directed to compounds of formula (I)	09-17-2009
20090253678	MACROCYCLIC PYRIMIDINE DERIVATIVES - Macrocyclic pyrimidine compounds, compositions comprising such compounds, methods for making the compounds, and methods of treating and preventing the progression of diseases, conditions, and disorders using such compounds and compositions are described herein.	10-08-2009
20100010055	ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USE THEREOF - The present invention is directed to compounds of formula (I)	01-14-2010
20110144057	ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USE THEREOF - The present invention is directed to compounds of formula (I)	06-16-2011
20110152250	CHROMANYLUREA COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR AND USES THEREOF - Compounds that are antagonists of the VR1 receptor, having formula (I)	06-23-2011

Patent applications by John R. Koenig, Chicago, IL US